Translational control of Toxoplasma gondii differentiation
Bioscience Reports · 22.04.2026 · 46 (4)
DOI: 10.1042/bsr20253672 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, online erschienen am 02.04.2026. Verfasst von Fengrong Wang. Beteiligte Einrichtung: Department of Biomedical Sciences, Iowa State University, Ames, IA 50010, U.S.A. Hauptthemen laut MEDLINE: Toxoplasma, Protein Biosynthesis, Toxoplasmosis, Protozoan Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association, Knights Templar Eye Foundation.
Abstract (Originalsprache)
Toxoplasma gondii is a globally prevalent protozoan parasite capable of establishing lifelong infections in its host. While acute infection is often asymptomatic, reactivation of latent bradyzoites can cause severe disease, particularly in immunocompromised individuals. Current therapies are ineffective against chronic infection, underscoring critical gaps in our understanding of bradyzoite biology and the molecular mechanisms governing stage conversion. Recent studies have identified translational control as a central regulator of T. gondii differentiation. This review highlights the roles of canonical translation initiation factors (eIF2α, eIF1.2, and eIF4E1), RNA-binding proteins (RBPs; BFD2/ROCY1, Alba1, and Alba2), and RNA modifications (with pseudouridylation representing the best-characterized modification currently linked to differentiation), as well as alternative splicing and non-coding RNAs in shaping stage-specific translational programs. This review further discusses underexplored mechanisms, including non-canonical initiation pathways, upstream open reading frames, transcript-level RNA modifications, ribosome heterogeneity and rRNA modifications, elongation and termination control, uncharacterized RBPs, and post-translational modifications of translation factors, that may coordinate proteome remodeling during differentiation. Together, established translational regulators and these emerging pathways highlight translational control as a central driver of parasite persistence and a promising therapeutic target for chronic toxoplasmosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Iowa State University, Ames, IA 50010, U.S.A.
- Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, U.S.A.
- Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109, U.S.A.
ORCID-Profile: Fengrong Wang
Förderung
- American Heart Association
- Knights Templar Eye Foundation
Zitieren
APA
Wang, F. (2026). Translational control of Toxoplasma gondii differentiation. Bioscience Reports, 46(4). https://doi.org/10.1042/bsr20253672
Vancouver
Wang F. Translational control of Toxoplasma gondii differentiation. Bioscience Reports. 2026;46(4). doi:10.1042/bsr20253672
BibTeX
@article{Wang2026,
author = {Wang, Fengrong},
title = {Translational control of Toxoplasma gondii differentiation},
journal = {Bioscience Reports},
year = {2026},
volume = {46},
number = {4},
doi = {10.1042/bsr20253672}
}
EUVIMED